Log in to save to my catalogue

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03158790v1

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

About this item

Full title

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2019-11, Vol.381 (19), p.1831-1842

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Patients treated with targeted temperature management (32 to 34°C) after cardiac arrest are at increased risk for early ventilator-associated pneumonia. In this multicenter trial, intravenous amoxicillin–clavulanate for 48 hours after cardiac arrest resulted in a lower incidence of early ventilator-associated pneumonia than placebo but did not affe...

Alternative Titles

Full title

Prevention of Early Ventilator-Associated Pneumonia after Cardiac Arrest

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_03158790v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03158790v1

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1812379

How to access this item